Setrobuvir (ANA-598) is an orally active non-nucleoside HCV NS5B polymerase inhibitor with inhibitory effects on de novo RNA synthesis and primer extension with IC50s between 4 and 5 nM. setrobuvir shows good binding affinity for SARS-CoV-2 RdRp and induces inhibition of RdRp.
Molecular Weight:
560.62
Purity:
>99.99%
CAS Number:
[1071517-39-9]
Formula:
C25H25FN4O6S2
Target:
SARS-CoV|||DNA/RNA Synthesis|||HCV Protease
T28762
* VAT and and shipping costs not included. Errors and price changes excepted
